Highlights from the transcatheter cardiovascular therapeutics conference 2010: Washington, DC, september 21-25, 2010

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 2, 2011, Pages 468-471

  Sun, Jack C J ^a   Ghanta, Ravi K ^a   Davidson, Michael J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNULOPLASTY; AORTA GRAFT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY SINUS; DISEASE SEVERITY; FOLLOW UP; HEART ATRIUM PACEMAKER; HEART CATHETERIZATION; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MITRAL VALVE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; SEPSIS; STROKE; SURGEON; SURGICAL TECHNIQUE; SURVIVAL; THORAX SURGERY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULOPLASTY;

AORTA, THORACIC; AORTIC VALVE; CARDIOVASCULAR DISEASES; CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MYOCARDIAL REVASCULARIZATION;

EID: 79960421145     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.04.013     Document Type: Conference Paper

References (29)

1. Leon MB, for the PARTNER trial investigators. Transcatheter aortic valve implantation in inoperable patients with severe aortic stenosis. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
2. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, L.G. Svensson PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
3. Rodes-Cabau J. Late follow-up from the Canadian Edwards TAVI Multicenter Registry: assessment of valve durability and predictors of mortality (early and late). Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
4. Wendler O. Comprehensive update on the global Edwards TAVI transapical studies (including SOURCE). Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
5. Thomas MR. The expanded (including cohort 2) SOURCE Registry: 30-day outcomes from 2,300 Edwards TAVI patients and predictors of mortality. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
6. Walther T. The single center Leipzig Edwards TAVI transapical experience: perspectives on TAVI vs. surgical AVR and late outcomes. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
7. Webb JG. Results from Edwards TAVI "valve-in-valve" treatment for bioprosthetic valve failure: lessons and future directions. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
8. Hijazi ZM. Final outcomes from the COMPASSION Edwards Pulmonic Valve U.S. Trial. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
9. Sack S. Early report from the PREVAIL Edwards SAPIEN XT Transfemoral Program. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
10. Meredith IT. The Australia-New Zealand Medtronic CoreValve Registry: VARC-adjudicated outcomes in inoperable and high Rrisk AS patients. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
11. Piazza N. Echocardiographic and angiographic insights from the two-year follow-up of the 18 Fr Medtronic CoreValve Safety and Efficacy Study. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
12. Serruys PW. SURTAVI: Design of a new randomized trial in lower risk AS patients. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
13. Popma JJ. The Medtronic CoreValve US Pivotal Trial: rationale, goals, and status review. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
14. Fontana GP. Progress with the St Jude Medical TAVI System. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
15. Vahanian A. First report from the Edwards Monarc Evolution II study. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
16. Goldberg SL. Emerging experiences and insights from the CDI Carillon. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
17. Sack S. The Viacor PTMA system and interim update on the PTOLEMY 2 study. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
18. Buellesfeld L. Emerging experiences and insights from Mitralign. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
19. Reisman M. Emerging experiences and insights from Guided Delivery Systems. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
20. Kuck KH. Recor first-in-human results. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
21. Buchbinder M. Progress toward a percutaneously adjustable mitral ring: Micardia. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
22. Piemonte TC. A catheter-based mitral valve spacer to reduce mitral regurgitation. Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
23. Glower, D. Anatomic predictors of mitral valve replacement: control surgery or surgery post MitraClip procedure. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
24. Sabik JF. The ValveXchange replaceable surgical tissue valve: concept and potential clinical applications. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
25. Quadri A. Transcatheter mitral valve implantation. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
26. Serruys PW. SYNTAX left main: three-year outcomes from a prospective randomized trial of Paclitaxel-eluting stents compared to bypass graft surgery in patients with left main coronary artery disease. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
27. Mohr FW. SYNTAX 3VD: Three-year outcomes from a prospective randomized trial of paclitaxel-eluting stents compared to bypass graft surgery in patients with triple vessel coronary artery disease. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
28. Dake MD. Thoracic endograft techniques: state of the art. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).
29. Bersin RM. Thoracic and abdominal aortic aneurysm grafts: lessons from the past, designs for the future. Transcatheter Cardiovascular Therapeutics (TCT); 2010 Sept 21-25; Washington (DC).